文献速递关节外科创伤骨科

COVID-19大流行是否与老年患者全髋关节置换术适应症中骨坏死增加有关

Did the COVID-19 Pandemic Coincide With an Increase in Osteonecrosis as Indication for Total Hip Arthroplasty in Older Patients?
PubMed 文献 · J Arthroplasty · 2023-06-12

这项回顾性队列研究利用2016至2021年全国大型数据库,比较2020至2021年与2016至2019年骨坏死发病率,并分析2020年4月至2021年12月队列中既往COVID-19诊断与骨坏死的关系。结果显示2020至2021年骨坏死发病率为1.6%(n=5,812),高于2016至2019年的1.4%(n=10,974),P<.0001;有COVID-19病史者骨坏死更常见(3.9%;130/3,313)相比无COVID-19病史者(3.0%;7,266/244,870),P=.001。结论认为骨坏死发病率在2020至2021年较前几年更高,且既往COVID-19诊断与骨坏死可能性增加相关。

要点

  • 2020至2021年全髋关节置换术中骨坏死发病率为1.6%,高于2016至2019年的1.4%(P<.0001)。
  • 有COVID-19病史者骨坏死发生率为3.9%(130/3,313),无COVID-19病史者为3.0%(7,266/244,870),P=.001。
  • 研究提示COVID-19大流行可能对骨坏死发病率增加起作用,需持续监测以充分了解其影响。

核心结论

  • 2020至2021年骨坏死发病率较之前年份更高,且既往COVID-19诊断与骨坏死可能性增加相关。
  • 这些发现提示COVID-19大流行在骨坏死发病率增加中可能起作用。
  • 需要持续监测以充分了解COVID-19大流行对全髋关节置换术诊疗和结局的影响。

研究设计与样本

  • 回顾性队列研究,利用2016至2021年全国大型数据库。
  • 比较2016至2019年与2020至2021年骨坏死发病率。
  • 利用2020年4月至2021年12月队列,分析既往COVID-19诊断与骨坏死的关系。
  • 两项比较均采用卡方检验。

主要发现

  • 2016至2021年共1,127,796例全髋关节置换术,2020至2021年骨坏死发病率为1.6%(n=5,812),2016至2019年为1.4%(n=10,974),P<.0001。
  • 2020年4月至2021年12月共248,183例全髋关节置换术,有COVID-19病史者骨坏死发生率为3.9%(130/3,313),无COVID-19病史者为3.0%(7,266/244,870),P=.001。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Osteonecrosis of the femoral head is a common indication for total hip arthroplasty (THA). It is unclear to what extent the COVID-19 pandemic has impacted its incidence. Theoretically, the combination of microvascular thromboses and corticosteroid use in patients who have COVID-19 may increase the risk of osteonecrosis. We aimed to (1) assess recent osteonecrosis trends and (2) investigate if a history of COVID-19 diagnosis is associated with osteonecrosis. METHODS: This retrospective cohort study utilized a large national database between 2016 and 2021. Osteonecrosis incidence in 2016 to 2019 was compared to 2020 to 2021. Secondly, utilizing a cohort from April 2020 through December 2021, we investigated whether a prior COVID-19 diagnosis was associated with osteonecrosis. For both comparisons, Chi-square tests were applied. RESULTS: Among 1,127,796 THAs performed between 2016 and 2021, we found an osteonecrosis incidence of 1.6% (n = 5,812) in 2020 to 2021 compared to 1.4% (n = 10,974) in 2016 to 2019; P < .0001. Furthermore, using April 2020 to December 2021 data from 248,183 THAs, we found that osteonecrosis was more common among those who had a history of COVID-19 (3.9%; 130 of 3,313) compared to patients who had no COVID-19 history (3.0%; 7,266 of 244,870); P = .001). CONCLUSION: Osteonecrosis incidence was higher in 2020 to 2021 compared to previous years and a previous COVID-19 diagnosis was associated with a greater likelihood of osteonecrosis. These findings suggest a role of the COVID-19 pandemic on an increased osteonecrosis incidence. Continued monitoring is necessary to fully understand the impact of the COVID-19 pandemic on THA care and outcomes.

来源:J Arthroplasty,查看原文。版权归原作者所有。

引用

  1. Okewunmi JO, Duey AH, Zubizarreta N, et al. Did the COVID-19 Pandemic Coincide With an Increase in Osteonecrosis as Indication for Total Hip Arthroplasty in Older Patients? J Arthroplasty. 2023. PMID: 37315633. doi:10.1016/j.arth.2023.06.007

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。